1. Home
  2. FCX vs SNY Comparison

FCX vs SNY Comparison

Compare FCX & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Freeport-McMoRan Inc.

FCX

Freeport-McMoRan Inc.

N/A

Current Price

$69.11

Market Cap

96.9B

ML Signal

N/A

Logo Sanofi ADS

SNY

Sanofi ADS

N/A

Current Price

$40.82

Market Cap

104.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FCX
SNY
Founded
1987
1994
Country
United States
France
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
96.9B
104.5B
IPO Year
1994
2001

Fundamental Metrics

Financial Performance
Metric
FCX
SNY
Price
$69.11
$40.82
Analyst Decision
Buy
Buy
Analyst Count
23
10
Target Price
★ $72.45
$53.72
AVG Volume (30 Days)
★ 7.9M
2.1M
Earning Date
10-22-2026
10-30-2026
Dividend Yield
0.86%
★ 4.28%
EPS Growth
N/A
N/A
EPS
★ 1.29
N/A
Revenue
★ $25,915,000,000.00
N/A
Revenue This Year
$14.52
$2.00
Revenue Next Year
$19.17
$6.29
P/E Ratio
$55.38
★ $6.14
Revenue Growth
★ 1.81
N/A
52 Week Low
$38.54
$40.40
52 Week High
$80.24
$52.68

Technical Indicators

Market Signals
Indicator
FCX
SNY
Relative Strength Index (RSI) 41.12 41.50
Support Level $66.29 $41.19
Resistance Level $70.66 $45.22
Average True Range (ATR) 1.93 0.46
MACD -0.49 -0.09
Stochastic Oscillator 19.77 38.62

Price Performance

Historical Comparison
FCX
SNY

About FCX Freeport-McMoRan Inc.

Freeport-McMoRan owns stakes in 10 copper mines, led by its 49% ownership of the Grasberg copper and gold operations in Indonesia, 55% of the Cerro Verde mine in Peru, and 72% of Morenci in Arizona. It sold around 1.1 million metric tons of copper (its share) in 2025, making it the one of the world's largest copper miners by volume. It also sold about 530,000 ounces of gold, mostly from Grasberg, and 74 million pounds of molybdenum. It had about 25 years of copper reserves at the end of December 2025. We expect it to sell about 1.3 million metric tons of copper and 610,000 ounces of gold midcycle in 2030.

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Share on Social Networks: